Author： Ong Shirley Bruner Janet Schellingerhout Dawid Puduvalli Vinay
Publisher： Springer Publishing Company
ISSN： 0167-594X
Source： Journal of Neuro-Oncology, Vol.102, Iss.3, 2011-05, pp. : 491-498
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Carboplatin and bevacizumab for recurrent malignant glioma
Oncology Letters, Vol. 4, Iss. 5, 2012-01 ,pp. :
Access to resources
Recommend
Low-dose fotemustine for recurrent malignant glioma: a multicenter phase II study
By Fabi Alessandra Metro Giulio Vidiri Antonello Lanzetta Gaetano Carosi Mariantonia Telera Stefano Maschio Marta Russillo Michelangelo Sperduti Isabella Carapella Carmine Cognetti Francesco Pace Andrea
Journal of Neuro-Oncology, Vol. 100, Iss. 2, 2010-11 ,pp. :
By Ernst-Stecken Antje Ganslandt Oliver Lambrecht Ulrike Sauer Rolf Grabenbauer Gerhard
Journal of Neuro-Oncology, Vol. 81, Iss. 3, 2007-02 ,pp. :
Towards optimizing the sequence of bevacizumab and nitrosoureas in recurrent malignant glioma
By Wiestler Benedikt Radbruch Alexander Osswald Matthias Combs Stephanie Jungk Christine Winkler Frank Bendszus Martin Unterberg Andreas Platten Michael Wick Wolfgang Wick Antje
Journal of Neuro-Oncology, Vol. 117, Iss. 1, 2014-03 ,pp. :